90
|
Galectin Therapeutics
gal 3 inhibitor gr-md-02 Gal 3 Inhibitor Gr Md 02, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/gal 3 inhibitor gr-md-02/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
gal 3 inhibitor gr-md-02 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
galectin-3 inhibitor belapectin gr-md-02 Galectin 3 Inhibitor Belapectin Gr Md 02, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/galectin-3 inhibitor belapectin gr-md-02/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
galectin-3 inhibitor belapectin gr-md-02 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
galectin-3 inhibitors  Galectin 3 Inhibitors, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/galectin-3 inhibitors/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
galectin-3 inhibitors - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
gal3 inhibitor gr-md-02 Gal3 Inhibitor Gr Md 02, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/gal3 inhibitor gr-md-02/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
gal3 inhibitor gr-md-02 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
galactoarabino-rhamnogalaturonan gr-md-02 Galactoarabino Rhamnogalaturonan Gr Md 02, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/galactoarabino-rhamnogalaturonan gr-md-02/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
galactoarabino-rhamnogalaturonan gr-md-02 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
protein inhibitors gcs-1.00 Protein Inhibitors Gcs 1.00, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/protein inhibitors gcs-1.00/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
protein inhibitors gcs-1.00 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
90
|
Galectin Therapeutics
3 inhibitor belapectin 3 Inhibitor Belapectin, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/3 inhibitor belapectin/product/Galectin Therapeutics Average 90 stars, based on 1 article reviews
3 inhibitor belapectin - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of the American College of Cardiology
Article Title: Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease
doi: 10.1016/j.jacc.2020.03.067
Figure Lengend Snippet: Biomarker Associations with Cancer and Cardiovascular Outcomes
Article Snippet: Cellular Proliferation , Galectin-3 , Mitogenic functions stimulating cellular proliferation Implicated in CV tissue remodeling, cardiac fibrosis , Overall survival ( 55 ) Disease or Progression-free survival ( 55 ) , Composite CV events (death, sudden death with resuscitation, hospitalization for HF, or administration of an intravenous inotropic or vasodilator drug for ≥4 hours without hospitalization) ( 46 ) All-cause mortality and rehospitalization due to HF ( 48 ) ,
Techniques: Biomarker Discovery